Skip to main content
. 2018 Oct 25;7(2):307–319. doi: 10.1007/s40120-018-0114-z

Fig. 2.

Fig. 2

Top panel: least squares mean (80% CI) change from baseline in MDS-UPDRS-III total score at day 22 in the MAD study. Bottom panel: number of l-dopa-free days in the MAD study. CI confidence interval, SAD single ascending dose, MDS-UPDRS-III Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale Part III